NFE2L2 and multiple sclerosis: Dimethyl fumarate, a potent NRF2 enhancer in treating multiple sclerosis, demonstrates neuroprotection against MPTP- and α-synuclein-induced neurotoxicity in mice by activating NRF2 and HO-1 [276,277].